Skip to main content
ConductScienceScienceDex

Yonathan Lissanu

NIH Rank #8103
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14325721Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Surgery

NIH Funding · FY2025

Linked Award Amount
$1.8M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#8,103
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Yonathan Lissanu. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Yonathan Lissanu as a PI. Multi-PI records show the full award amount for context.

  • 4R37CA251629-06R37
    Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer
    UT MD Anderson Cancer Center
    $952.8K
    award amount
  • 5R01CA272945-04R01
    Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancer
    UT MD Anderson Cancer Center
    $537.6K
    award amount
  • 1R21CA295906-01R21
    Targeting SMARCA2 to overcome resistance of SMARCA4-mutant lung cancer to KRAS G12C inhibitors
    UT MD Anderson Cancer Center
    $267.5K
    award amount

Award organization

Organizations that administered FY2025 awards listing Yonathan Lissanu as a PI.

FY2025 award administered by UT MD Anderson Cancer Center (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #8103
  6. 2025
    R01 Grant Holder

Explore further

Find collaborators for Yonathan Lissanu

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →